High-throughput primary B cell cytokines assay for drug screening in multiple sclerosis
Ming-Mei Shang, Yufei Cheng, Nicolas Ruffin, André Ortlieb Guerreiro‐Cacais et autres
0 citationsBiomedicine & Pharmacotherapy
Ming-Mei Shang
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
37Publications signalées
1115Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Atherosclerosis and Cardiovascular DiseasesComputational Drug Discovery MethodsT-cell and B-cell ImmunologySystemic Lupus Erythematosus ResearchLipoproteins and Cardiovascular Health
Publications récentes
Extracts of Gleditsia sinensis Lam. thorn ameliorates ulcerative colitis through PPARγ/GPX4 pathway-mediated inhibition of enterocyte ferroptosis
Zi-Yun Zhuo, Xiao-Ya Guo, Xiaoming Liu, Ming-Mei Shang et autres
0 citationsWorld Journal of Gastroenterology
Bioactivity-guided isolation of anti-inflammatory compounds from the herbs constituting a traditional Chinese medicine formulation used for the treatment of rheumatoid arthritis
Janika Welzel, Luke P. Robertson, Louisa Brieskorn, Iro Chaitoglou et autres
1 citationPhytomedicine
Combining computational target prioritization and a B cell maturation assay for target evaluation studies in systemic lupus erythematosus
Ming-Mei Shang, Zhuang Liu, Bogdan Knezevic, Christine Möller Westerberg et autres
0 citationsTranslational research
Machine Learning Dose Prediction for Automated Proton Therapy Planning in Esophageal Cancer
M. Zarenia, Matthew Wells, Ming-Mei Shang, Peter R. Jermain et autres
0 citationsInternational Journal of Radiation Oncology*Biology*Physics
Domain-Specific Quality-of-Life Outcomes in GI Malignancies: A Comparative Analysis of SBRT, PBT and IMRT
Nakul Gupta, Vinay Sharma, Ming-Mei Shang, Marielle Fis Loperena et autres
0 citationsInternational Journal of Radiation Oncology*Biology*Physics
529P PIK3CA mutation profiles in primary and metastatic lesions in chinese patients with hormone receptor-positive, HER2-negative breast cancer
Gang Xu, Tong Liu, Yi Cai, Miao Ma et autres
0 citationsAnnals of Oncology
Chemogenomic Screening in a Patient‐Derived 3D Fatty Liver Disease Model Reveals the CHRM1‐TRPM8 Axis as a Novel Module for Targeted Intervention
Sonia Youhanna, Aurino M. Kemas, Shane C. Wright, Yi Zhong et autres
24 citationsAdvanced Science
Patient Reported Quality of Life after Chemoradiation for Esophageal Cancer: Analysis of Clinical and Dosimetric Predictors
Neeti Gupta, Vishnu Sharma, Ming-Mei Shang, Alireza Sharif et autres
1 citationInternational Journal of Radiation Oncology*Biology*Physics
OTUD1 ameliorates cerebral ischemic injury through inhibiting inflammation by disrupting K63-linked deubiquitination of RIP2
Shengnan Zheng, Yiquan Li, Xiaomeng Song, Mengting Wu et autres
28 citationsJournal of Neuroinflammation
High‐content screening of drug combinations of an mPGES ‐1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance
Ahlem Zaghmi, Erdem Aybay, Long Jiang, Ming-Mei Shang et autres
10 citationsMolecular Oncology
Author response for "High‐content screening of drug combinations of an mPGES ‐1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance"
Ahlem Zaghmi, Erdem Aybay, Long Jiang, Ming-Mei Shang et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.